k Fibrodysplasia ossificans progressiva mutant protein Molecular model of a mutant copy of the activin A receptor type I ACVR1 protein brown and light pink that causes the rare genetic disease fibrodysplasia ossificans progressiva FOP. FOP is a disease where fibrous tissues, including muscle, tendons and ligaments, are gradually replaced by bone ossified. A mutation in the ACVR1 gene, which plays a role in the bone morphogenic protein BMP pathway, leads to a change in amino acid at position 206, where arginine is swapped for histidine rod shaped. This decreases the affinity of the ACVR1 protein for its inhibitor FK506binding protein 12 FKB12, yellow, leading to increased activity of the protein and therefore increased production of bone., Photo by RAMON ANDRADE 3DCIENCIASCIENCE PHOTO LIBRARY Stock Photo - Afloimages
Sign up
Login
All images
Fibrodysplasia ossificans progressiva mutant protein Molecular model of a mutant copy of the activin A receptor type I  ACVR1  protein  brown and light pink  that causes the rare genetic disease fibrodysplasia ossificans progressiva  FOP . FOP is a disease where fibrous tissues, including muscle, tendons and ligaments, are gradually replaced by bone  ossified . A mutation in the ACVR1 gene, which plays a role in the bone morphogenic protein  BMP  pathway, leads to a change in amino acid at position 206, where arginine is swapped for histidine  rod shaped . This decreases the affinity of the ACVR1 protein for its inhibitor FK506 binding protein 12  FKB12, yellow , leading to increased activity of the protein and therefore increased production of bone., Photo by RAMON ANDRADE 3DCIENCIA SCIENCE PHOTO LIBRARY
RM

Fibrodysplasia ossificans progressiva mutant protein

Molecular model of a mutant copy of the activin A receptor type I (ACVR1) protein (brown and light pink) that causes the rare genetic disease fibrodysplasia ossificans progressiva (FOP). FOP is a disease where fibrous tissues, including muscle, tendons and ligaments, are gradually replaced by bone (ossified). A mutation in the ACVR1 gene, which plays a role in the bone morphogenic protein (BMP) pathway, leads to a change in amino acid at position 206, where arginine is swapped for histidine (rod shaped). This decreases the affinity of the ACVR1 protein for its inhibitor FK506-binding protein 12 (FKB12, yellow), leading to increased activity of the protein and therefore increased production of bone., Photo by RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY

Details

ID
180851673

Collection

License type
Rights Managed

Photographer



Sign in
Member access
Login not found.